A Retrospective Register Study to Map the Frequency of Short Duration Atrial Fibrillation (AF) Among All Patients Admitted to Roskilde Sygehus in Denmark in 2010

NCT ID: NCT01502176

Last Updated: 2011-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-12-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective observational study of patients with atrial fibrillation admitted to Roskilde University Hospital in 2010.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a retrospective register study of all patients discharged from Roskilde Hospital with a primary diagnosis of AF in 2010. All data will be collected from the patient's medical records and only data from this specific admission will be recorded. No follow-up of the patients after discharge will be performed in this study. The study does not involve any randomization or any drug testing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type of Atrial Fibrillation Medical History Current Treatment Complications

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

atrial fibrillation registry

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Atrial fibrillation patients

All patients discharged from hospital with a diagnose of atrial fibrillation

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Atrial fibrillation

Exclusion Criteria

* None
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role collaborator

Zealand University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ole Dyg Pedersen

Medical doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Roskilde University Hospital

Roskilde, Copenhagen, Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ole D Pedersen, MD

Role: CONTACT

Phone: +45463232

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ole D Pedersen, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MISP Proposal # 38233

Identifier Type: -

Identifier Source: org_study_id